{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:26Z","timestamp":1791348626178,"version":"4.3.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000082","name":"Division of Graduate Education","doi-asserted-by":"publisher","award":["2139899"],"award-info":[{"award-number":["2139899"]}],"id":[{"id":"10.13039\/100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000147","name":"Division of Civil, Mechanical and Manufacturing Innovation","doi-asserted-by":"publisher","award":["2245367"],"award-info":[{"award-number":["2245367"]}],"id":[{"id":"10.13039\/100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000078","name":"Division of Materials Research","doi-asserted-by":"publisher","award":["1719875"],"award-info":[{"award-number":["1719875"]}],"id":[{"id":"10.13039\/100000078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000165","name":"Division of Chemistry","doi-asserted-by":"publisher","award":["1531632"],"award-info":[{"award-number":["1531632"]}],"id":[{"id":"10.13039\/100000165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["S10OD032251"],"award-info":[{"award-number":["S10OD032251"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016958","name":"Office of Research Infrastructure Programs, National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD025049"],"award-info":[{"award-number":["S10OD025049"]}],"id":[{"id":"10.13039\/100016958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11095-026-04196-z","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:09:51Z","timestamp":1789675791000},"page":"2967-2988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Controlled Release of the IL-1R Antagonist, Anakinra, from Microgels with an Extended Intra-articular Residence Time"],"prefix":"10.1007","volume":"43","author":[{"given":"Ruben J.","family":"Trujillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Bonassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0794-4915","authenticated-orcid":false,"given":"David","family":"Putnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"4196_CR1","unstructured":"CDC, Arthritis Related Statistics; 2023 May 11. Available from: https:\/\/www.cdc.gov\/arthritis\/osteoarthritis\/index.html. Accessed Aug 2025."},{"key":"4196_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones S, Palmer AJR, Agricola R, Price AJ, Vincent TL, Weinans H, et al. Osteoarthritis. Lancet. 2015;386:376\u201387.","journal-title":"Lancet"},{"key":"4196_CR3","doi-asserted-by":"publisher","first-page":"100587","DOI":"10.1016\/j.eclinm.2020.100587","volume":"29\u201330","author":"A Cui","year":"2020","unstructured":"Cui A, Li H, Wang H, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020;29\u201330:100587.","journal-title":"EClinicalMedicine"},{"key":"4196_CR4","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1177\/0363546508326984","volume":"37","author":"EJ Strauss","year":"2009","unstructured":"Strauss EJ, Hart JA, Miller MD, Altman RD, Rosen JE. Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions. Am J Sports Med. 2009;37:1636\u201344.","journal-title":"Am J Sports Med"},{"key":"4196_CR5","doi-asserted-by":"publisher","unstructured":"J\u00fcni P, Hari R, Rutjes AWS, Fischer R, Silletta MG, Reichenbach S, da Costa BR. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005328.pub3.","DOI":"10.1002\/14651858.CD005328.pub3"},{"key":"4196_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1056\/NEJMct1215534","volume":"11","author":"DJ Hunter","year":"2015","unstructured":"Hunter DJ. Clinical Therapeutics Viscosupplementation for Osteoarthritis of the Knee. N Engl J Med. 2015;11:1040\u20137.","journal-title":"N Engl J Med"},{"key":"4196_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/11599350-000000000-00000","volume":"29","author":"Z Jotanovic","year":"2012","unstructured":"Jotanovic Z, Mihelic R, Sestan B, Dembic Z. Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review. Drugs Aging. 2012;29:343\u201358.","journal-title":"Drugs Aging"},{"key":"4196_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, van der Meer JWM. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discovery. 2012;11:633\u201352.","journal-title":"Nat Rev Drug Discovery"},{"key":"4196_CR9","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720\u201332.","journal-title":"Blood"},{"key":"4196_CR10","doi-asserted-by":"publisher","unstructured":"Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges. 2016; preprint, https:\/\/doi.org\/10.1016\/j.bone.2016.01.019.","DOI":"10.1016\/j.bone.2016.01.019"},{"key":"4196_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2741\/1817","volume":"11","author":"PS Burrage","year":"2006","unstructured":"Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;11:529\u201343.","journal-title":"Front Biosci"},{"key":"4196_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-024-05310-9","author":"NC Budhiparama","year":"2024","unstructured":"Budhiparama NC, Putramega D, Lumban-Gaol I. Orthobiologics in knee osteoarthritis, dream or reality? Arch Orthop Trauma Surg. 2024. https:\/\/doi.org\/10.1007\/s00402-024-05310-9.","journal-title":"Arch Orthop Trauma Surg"},{"key":"4196_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-83025-2","volume":"11","author":"H Bansal","year":"2021","unstructured":"Bansal H, Leon J, Pont JL, Wilson DA, Bansal A, Agarwal D, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: correct dose critical for long term clinical efficacy. Sci Rep. 2021;11:1\u201310.","journal-title":"Sci Rep"},{"key":"4196_CR14","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00167-012-2329-3","volume":"21","author":"G Filardo","year":"2013","unstructured":"Filardo G, Madry H, Jelic M, Roffi A, Cucchiarini M, Kon E. Mesenchymal stem cells for the treatment of cartilage lesions: From preclinical findings to clinical application in orthopaedics. Knee Surg Sports Traumatol Arthrosc. 2013;21:1717\u201329.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"4196_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00441-018-2884-0","volume":"375","author":"SA Muhammad","year":"2019","unstructured":"Muhammad SA, Nordin N, Mehat MZ, Fakurazi S. Comparative efficacy of stem cells and secretome in articular cartilage regeneration: a systematic review and meta-analysis. Cell Tissue Res. 2019;375:329\u201344.","journal-title":"Cell Tissue Res"},{"key":"4196_CR16","first-page":"1317","volume":"32","author":"X Chevalier","year":"2005","unstructured":"Chevalier X, Giraudeau B, Conrozier T, Marliere J, Kiefer P, Goupille P. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: A multicenter study. J Rheumatol. 2005;32:1317\u201323.","journal-title":"J Rheumatol"},{"key":"4196_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.joca.2014.09.006","volume":"23","author":"KA Elsaid","year":"2015","unstructured":"Elsaid KA, Zhang L, Shaman Z, Patel C, Schmidt TA, Jay GD. The Impact of Early Intra-Articular Administration of Interleukin-1 Receptor Antagonist on Lubricin Metabolism and Cartilage Degeneration in an Anterior Cruciate Ligament Transection Model KA. Osteoarthritis Cartilage. 2015;23:114\u201321.","journal-title":"Osteoarthritis Cartilage"},{"key":"4196_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.joca.2011.12.009","volume":"20","author":"VB Kraus","year":"2012","unstructured":"Kraus VB, Birmingham J, Stabler TV, Feng S, Taylor DC, Moorman CT, et al. Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage. 2012;20:271\u20138.","journal-title":"Osteoarthritis Cartilage"},{"key":"4196_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrrheum.2013.159","volume":"10","author":"CH Evans","year":"2014","unstructured":"Evans CH, Kraus VB, Setton LA. Progress in intra-articular therapy. Nat Rev Rheumatol. 2014;10:11\u201322.","journal-title":"Nat Rev Rheumatol"},{"key":"4196_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1021\/acs.accounts.6b00536","volume":"50","author":"N Oliva","year":"2017","unstructured":"Oliva N, Conde J, Wang K, Artzi N. Designing hydrogels for on-demand therapy. Acc Chem Res. 2017;50:669\u201379.","journal-title":"Acc Chem Res"},{"key":"4196_CR21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1021\/ar900035f","volume":"42","author":"ME Fox","year":"2009","unstructured":"Fox ME, Szoka FC, Fr\u00e9chet JMJ. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res. 2009;42:1141\u201351.","journal-title":"Acc Chem Res"},{"key":"4196_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13018-023-03590-2","volume":"18","author":"L Yu","year":"2023","unstructured":"Yu L, Luo R, Qin G, Zhang Q, Liang W. Efficacy and safety of anti-interleukin-1 therapeutics in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res. 2023;18:1\u201316.","journal-title":"J Orthop Surg Res"},{"key":"4196_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.joca.2008.06.014","volume":"17","author":"AWA Baltzer","year":"2009","unstructured":"Baltzer AWA, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage. 2009;17:152\u201360.","journal-title":"Osteoarthritis Cartilage"},{"key":"4196_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/art.24096","volume":"61","author":"X Chevalier","year":"2009","unstructured":"Chevalier X, Goupille P, Beaulieu AD, Burch FX, Bensen WG, Conrozier T, et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Care Res (Hoboken). 2009;61:344\u201352.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4196_CR25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.joca.2007.07.008","volume":"16","author":"KGA Yang","year":"2008","unstructured":"Yang KGA, Raijmakers NJH, van Arkel ERA, Caron JJ, Rijk PC, Willems WJ, et al. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarthritis Cartilage. 2008;16:498\u2013505.","journal-title":"Osteoarthritis Cartilage"},{"key":"4196_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6290957","author":"B Qiu","year":"2016","unstructured":"Qiu B, Gong M, He QT, Zhou PH. Controlled release of interleukin-1 receptor antagonist from hyaluronic acid-chitosan microspheres attenuates interleukin-1 \u03b2 -induced inflammation and apoptosis in chondrocytes. BioMed Res Int. 2016. https:\/\/doi.org\/10.1155\/2016\/6290957.","journal-title":"BioMed Res Int"},{"key":"4196_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbm.a.35601","volume":"104A","author":"R Agarwal","year":"2016","unstructured":"Agarwal R, Volkmer TM, Wang P, Lee LA, Wang Q, Garc\u00eda AJ. Synthesis of self-assembled IL-1Ra-presenting nanoparticles for the treatment of osteoarthritis. J Biomed Mater Res A. 2016;104A:595\u20139.","journal-title":"J Biomed Mater Res A"},{"key":"4196_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-019-2003-y","volume":"21","author":"S Mehta","year":"2019","unstructured":"Mehta S, Akhtar S, Porter RM, \u00d6nnerfjord P, Bajpayee AG. Interleukin-1 receptor antagonist (IL-1Ra) is more effective in suppressing cytokine-induced catabolism in cartilage-synovium co-culture than in cartilage monoculture. Arthritis Res Ther. 2019;21:1\u201315.","journal-title":"Arthritis Res Ther"},{"key":"4196_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.joca.2023.01.573","volume":"31","author":"S Mehta","year":"2023","unstructured":"Mehta S, Boyer TL, Akhtar S, He T, Zhang C, Vedadghavami A, et al. Sustained intra-cartilage delivery of interleukin-1 receptor antagonist using cationic peptide and protein-based carriers. Osteoarthritis Cartilage. 2023;31:780\u201392.","journal-title":"Osteoarthritis Cartilage"},{"key":"4196_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1560\/DYBG-TWDV-J8PF-7W9T","volume":"45","author":"G Lavi","year":"2005","unstructured":"Lavi G, Dinarello CA, Apte RN, Cohen S. Sustained release of IL-1Ra from biodegradable microspheres prolongs its IL-1-neutralizing effects. Isr J Chem. 2005;45:457\u201364.","journal-title":"Isr J Chem"},{"key":"4196_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nrrheum.2009.121","volume":"5","author":"J Martel-Pelletier","year":"2009","unstructured":"Martel-Pelletier J, Pelletire JP. A single injection of anakinra for treating knee OA? Nat Rev Rheumatol. 2009;5:363\u20134.","journal-title":"Nat Rev Rheumatol"},{"key":"4196_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.actbio.2019.04.051","volume":"93","author":"AEB Clements","year":"2019","unstructured":"Clements AEB, Murphy WL. Injectable biomaterials for delivery of interleukin-1 receptor antagonist: toward improving its therapeutic effect. Acta Biomater. 2019;93:123\u201334.","journal-title":"Acta Biomater"},{"key":"4196_CR33","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s11095-013-1118-0","volume":"30","author":"MSJ Akash","year":"2013","unstructured":"Akash MSJ, Rehman K, Chen S. IL-1Ra and its delivery strategies: inserting the association in perspective. Pharm Res. 2013;30:2951\u201366.","journal-title":"Pharm Res"},{"key":"4196_CR34","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1016\/j.bmc.2007.05.061","volume":"15","author":"P Yu","year":"2007","unstructured":"Yu P, Zheng C, Chen J, Zhang G, Liu Y, Suo X, et al. Investigation on PEGylation strategy of recombinant human interleukin-1 receptor antagonist. Bioorg Med Chem. 2007;15:5396\u2013405.","journal-title":"Bioorg Med Chem"},{"key":"4196_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/71916","volume":"18","author":"G Zhu","year":"2000","unstructured":"Zhu G, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable poly (lactide-co- glycolide). Nat Biotechnol. 2000;18:52\u20137.","journal-title":"Nat Biotechnol"},{"key":"4196_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/088532829701200103","volume":"12","author":"MJ Davies","year":"1997","unstructured":"Davies MJ, Mitchell CA, Maley MAL, Grounds MD, Harvey AR, Plant GW, et al. In vitro assessment of the biological activity of basic fibroblast growth factor relesed from various polymers and biomatrices. J Biomater Appl. 1997;12:31\u201356.","journal-title":"J Biomater Appl"},{"key":"4196_CR37","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/jps.22054","volume":"99","author":"SP Dipak","year":"2010","unstructured":"Dipak SP, Kosloski MP, Balu-Iyer SV. Delivery of Therapeutic Proteins. J Pharm Sci. 2010;99:2557\u201375.","journal-title":"J Pharm Sci"},{"key":"4196_CR38","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s11095-015-1834-8","volume":"33","author":"JL Rios","year":"2016","unstructured":"Rios JL, Lu G, Seo NE, Lambert T, Putnam D. Prolonged release of bioactive model proteins from anionic microgels fabricated with a new microemulsion approach. Pharm Res. 2016;33:879\u201392.","journal-title":"Pharm Res"},{"key":"4196_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0939-6411(00)00090-4","volume":"50","author":"NA Peppas","year":"2000","unstructured":"Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm. 2000;50:27\u201346.","journal-title":"Eur J Pharm Biopharm"},{"key":"4196_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/rb\/rbab060","volume":"8","author":"JT Peters","year":"2021","unstructured":"Peters JT, Wechsler ME, Peppas NA. Advanced biomedical hydrogels: molecular architecture and its impact on medical applications. Regen Biomater. 2021;8:1\u201321.","journal-title":"Regen Biomater"},{"key":"4196_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtla.2023.102000","volume":"33","author":"RJ Trujillo","year":"2024","unstructured":"Trujillo RJ, Tam AT, Bonassar LJ, Putnam D. Effective viscous lubrication of cartilage with low viscosity microgels. Materialia. 2024;33:102000.","journal-title":"Materialia"},{"key":"4196_CR42","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/macp.201200528","volume":"213","author":"JM Pelet","year":"2012","unstructured":"Pelet JM, Putnam D. Poly(acrylic acid ) Undergoes Partial Esterification During RAFT Synthesis in Methanol and Interchain Disulfide Bridging Upon NaOH Treatment. Macromol Chem Phys. 2012;213:2536\u201340.","journal-title":"Macromol Chem Phys"},{"key":"4196_CR43","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1021\/ma801433g","volume":"42","author":"JM Petet","year":"2009","unstructured":"Petet JM, Putnam D. High Molecular Weight Poly(methacrylic acid) with Narrow Polydispersity by RAFT Polymerization. Macromolecules. 2009;42:1494\u20139.","journal-title":"Macromolecules"},{"key":"4196_CR44","first-page":"1","volume":"41","author":"K Vishwanath","year":"2022","unstructured":"Vishwanath K, McClure SR, Bonassar LJ. Polyacrylamide hydrogel lubricates cartilage after biochemical degradation and mechanical injury. J Orthop Res. 2022;41:1\u20139.","journal-title":"J Orthop Res"},{"key":"4196_CR45","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/jor.23782","volume":"36","author":"ED Bonnevie","year":"2018","unstructured":"Bonnevie ED, Galesso D, Secchieri C, Bonassar LJ. Degradation alters the lubrication of articular cartilage by high viscosity, hyaluronic acid-based lubricants. J Orthop Res. 2018;36:1456\u201364.","journal-title":"J Orthop Res"},{"key":"4196_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1006\/abio.1996.0502","volume":"243","author":"BO Enobakhare","year":"1996","unstructured":"Enobakhare BO, Bader DL, Lee DA. Quantification of sulfated glycosaminoglycans in chondrocyte\/alginate cultures, by use of 1,9-dimethylmethylene blue. Anal Biochem. 1996;243:189\u201391.","journal-title":"Anal Biochem"},{"key":"4196_CR47","doi-asserted-by":"publisher","first-page":"7787","DOI":"10.1016\/j.actbio.2013.05.002","volume":"9","author":"JL Puetzer","year":"2013","unstructured":"Puetzer JL, Bonassar LJ. High density type i collagen gels for tissue engineering of whole menisci. Acta Biomater. 2013;9:7787\u201395.","journal-title":"Acta Biomater"},{"key":"4196_CR48","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/jor.22334","volume":"31","author":"AL McNulty","year":"2013","unstructured":"McNulty AL, Rothfusz NE, Leddy HA, Guilak F. Synovial fluid concentrations and relative potency of interleukin-1 alpha and beta in cartilage and meniscus degradation. J Orthop Res. 2013;31:1039\u201345.","journal-title":"J Orthop Res"},{"key":"4196_CR49","first-page":"422","volume":"72","author":"SJ Hopkins","year":"1988","unstructured":"Hopkins SJ, Humphreys M, Jayson MI. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol. 1988;72:422\u20137.","journal-title":"Clin Exp Immunol."},{"key":"4196_CR50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41565-024-01747-6","volume":"20","author":"L Xue","year":"2024","unstructured":"Xue L, Zhao G, Gong N, Han X, Shepherd SJ, Xiong X, et al. Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery. Nat Nanotechnol. 2024;20:132\u201343.","journal-title":"Nat Nanotechnol"},{"key":"4196_CR51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jconrel.2004.05.009","volume":"98","author":"M Leonard","year":"2004","unstructured":"Leonard M, De Boisseson MR, Hubert P, Dalen\u00e7on F, Dellacherie E. Hydrophobically modified alginate hydrogels as protein carriers with specific controlled release properties. J Control Release. 2004;98:395\u2013405.","journal-title":"J Control Release"},{"key":"4196_CR52","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/term.267","volume":"4","author":"L Solorio","year":"2010","unstructured":"Solorio L, Zwolinski C, Lund AW, Farrell MJ, Stegemann JP. Gelatin microspheres crosslinked with genipin for local delivery of growth factors. J Tissue Eng Regen Med. 2010;4:514\u201323.","journal-title":"J Tissue Eng Regen Med"},{"key":"4196_CR53","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/jps.10122","volume":"91","author":"S Ozba\u015f-Turan","year":"2002","unstructured":"Ozba\u015f-Turan S, Akbuga J, Aral C. Controlled release of interleukin-2 from chitosan microspheres. J Pharm Sci. 2002;91:1245\u201351.","journal-title":"J Pharm Sci"},{"key":"4196_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.11.023","volume":"221","author":"MC Koetting","year":"2016","unstructured":"Koetting MC, Guido JF, Gupta M, Zhang A, Peppas NA. pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: effects of protein size, crosslinking density, and hydrogel degradation on protein delivery. J Control Release. 2016;221:18\u201325.","journal-title":"J Control Release"},{"key":"4196_CR55","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/mabi.200800317","volume":"9","author":"J Lee","year":"2009","unstructured":"Lee J, Lee KY. Injectable microsphere\/hydrogel combination systems for localized protein delivery. Macromol Biosci. 2009;9:671\u20136.","journal-title":"Macromol Biosci"},{"key":"4196_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adhm.201800263","volume":"7","author":"AEB Clements","year":"2018","unstructured":"Clements AEB, Groves ER, Chamberlain CS, Vanderby R, Murphy WL. Microparticles locally deliver active interleukin-1 receptor antagonist in vivo. Adv Healthc Mater. 2018;7:1\u20138.","journal-title":"Adv Healthc Mater"},{"key":"4196_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/026520499289022","volume":"16","author":"S Takka","year":"1999","unstructured":"Takka S, Acart\u00fcrk F. Calcium alginate microparticles for oral administration. I: Effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsulation. 1999;16:275\u201390.","journal-title":"J Microencapsulation."},{"key":"4196_CR58","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.foodhyd.2016.03.015","volume":"58","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Zhang R, Zou L, McClements DJ. Protein encapsulation in alginate hydrogel beads: effect of pH on microgel stability, protein retention and protein release. Food Hydrocoll. 2016;58:308\u201315.","journal-title":"Food Hydrocoll"},{"key":"4196_CR59","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ijbiomac.2020.11.126","volume":"168","author":"T Kopa\u010d","year":"2021","unstructured":"Kopa\u010d T, Krajnc M, Ru\u010digaj A. A mathematical model for pH-responsive ionically crosslinked TEMPO nanocellulose hydrogel design in drug delivery systems. Int J Biol Macromol. 2021;168:695\u2013707.","journal-title":"Int J Biol Macromol"},{"key":"4196_CR60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ijbiomac.2020.05.088","volume":"159","author":"T Kopa\u010d","year":"2020","unstructured":"Kopa\u010d T, Ru\u010digaj A, Krajnc M. The mutual effect of the crosslinker and biopolymer concentration on the desired hydrogel properties. Int J Biol Macromol. 2020;159:557\u201369.","journal-title":"Int J Biol Macromol"},{"key":"4196_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0168-3659(01)00379-0","volume":"75","author":"S Zhou","year":"2001","unstructured":"Zhou S, Deng X, Li X. Investigation on a novel core-coated microspheres protein delivery system. J Control Release. 2001;75:27\u201336.","journal-title":"J Control Release"},{"key":"4196_CR62","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1006\/abbi.1997.0205","volume":"344","author":"LJ Bonassar","year":"1997","unstructured":"Bonassar LJ, Sandy JD, Lark MW, Plaas AHK, Frank EH, Grodzinsky AJ. Inhibition of cartilage degradation and changes in physical properties induced by IL-1\u03b2 and retinoic acid using matrix metalloproteinase inhibitors. Arch Biochem Biophys. 1997;344:404\u201312.","journal-title":"Arch Biochem Biophys"},{"key":"4196_CR63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/art.1780380205","volume":"38","author":"LJ Bonassar","year":"1995","unstructured":"Bonassar LJ, Frank EH, Murray JC, Paguio CG, Moore VL, Lark MW, et al. Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum. 1995;38:173\u201383.","journal-title":"Arthritis Rheum"},{"key":"4196_CR64","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1021\/acsbiomaterials.4c00908","volume":"10","author":"M Prajapati","year":"2024","unstructured":"Prajapati M, Vishwanath K, Huang L, Colville M, Reesink H, Paszek M, et al. Specific Degradation of the Mucin Domain of Lubricin in Synovial Fluid Impairs Cartilage Lubrication. ACS Biomater Sci Eng. 2024;10:6915\u201326.","journal-title":"ACS Biomater Sci Eng"},{"key":"4196_CR65","first-page":"1","volume":"41","author":"K Vishwanath","year":"2022","unstructured":"Vishwanath K, McClure SR, Bonassar LJ. Polyacrylamide hydrogel lubricates cartilage after biochemical degradation and mechanical injury. J Orthop Res. 2022;41:1\u20139.","journal-title":"J Orthop Res"},{"key":"4196_CR66","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.3390\/ijms22158005","volume":"22","author":"CM Khella","year":"2021","unstructured":"Khella CM, Horvath JM, Asgarian R, Rolauffs B, Hart ML. Anti-inflammatory therapeutic approaches to prevent or delay post-traumatic osteoarthritis (Ptoa) of the knee joint with a focus on sustained delivery approaches. Int J Mol Sci. 2021;22:8005.","journal-title":"Int J Mol Sci"},{"key":"4196_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrrheum.2010.178","volume":"7","author":"DJ Hunter","year":"2011","unstructured":"Hunter DJ. Pharmacologic therapy for osteoarthritis-the era of disease modification. Nat Rev Rheumatol. 2011;7:13\u201322.","journal-title":"Nat Rev Rheumatol"},{"key":"4196_CR68","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.addr.2006.01.018","volume":"58","author":"N Gerwin","year":"2006","unstructured":"Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev. 2006;58:226\u201342.","journal-title":"Adv Drug Deliv Rev"},{"key":"4196_CR69","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1016\/j.biomaterials.2013.12.076","volume":"35","author":"P Chen","year":"2014","unstructured":"Chen P, Zhu S, Wang Y, Mu Q, Wu Y, Xia Q, et al. The amelioration of cartilage degeneration by ADAMTS-5 inhibitor delivered in a hyaluronic acid hydrogel. Biomaterials. 2014;35:2827\u201336.","journal-title":"Biomaterials"},{"key":"4196_CR70","first-page":"1","volume":"22","author":"Q Hu","year":"2021","unstructured":"Hu Q, Ecker M. Overview of MMP-13 as a promising target for the treatment of osteoarthritis. Int J Mol Sci. 2021;22:1\u201322.","journal-title":"Int J Mol Sci"},{"key":"4196_CR71","doi-asserted-by":"publisher","first-page":"561459","DOI":"10.1155\/2014\/561459","volume":"2014","author":"P Wojdasiewicz","year":"2014","unstructured":"Wojdasiewicz P, Poniatowski AA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014;2014:561459.","journal-title":"Mediators Inflamm"},{"key":"4196_CR72","first-page":"1","volume":"24","author":"M Laavola","year":"2019","unstructured":"Laavola M, Lepp\u00e4nen T, H\u00e4m\u00e4l\u00e4inen M, Vuolteenaho K, Moilanen T, Nieminen R, et al. IL-6 in osteoarthritis: effects of pine stilbenoids. Molecules. 2019;24:1\u201311.","journal-title":"Molecules"},{"key":"4196_CR73","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1002\/jps.21346","volume":"97","author":"C Larsen","year":"2008","unstructured":"Larsen C, \u00d8stergaard J, Larsen SW, Jensen H, Jacobsen S, Lindegaard C, et al. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J Pharm Sci. 2008;97:4622\u201354.","journal-title":"J Pharm Sci"},{"key":"4196_CR74","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.drudis.2018.05.023","volume":"23","author":"P Maudens","year":"2018","unstructured":"Maudens P, Jordan O, All\u00e9mann E. Recent advances in intra-articular drug delivery systems for osteoarthritis therapy. Drug Discovery Today. 2018;23:1761\u201375.","journal-title":"Drug Discovery Today"},{"key":"4196_CR75","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1016\/j.bioactmat.2021.03.022","volume":"6","author":"Y Han","year":"2021","unstructured":"Han Y, Yang J, Zhao W, Wang H, Sun Y, Chen Y, et al. Biomimetic injectable hydrogel microspheres with enhanced lubrication and controllable drug release for the treatment of osteoarthritis. Bioactive Materials. 2021;6:3596\u2013607.","journal-title":"Bioactive Materials"},{"key":"4196_CR76","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1021\/acsbiomaterials.8b00116","volume":"4","author":"MJ Sandker","year":"2018","unstructured":"Sandker MJ, Duque LF, Redout EM, Klijnstra EC, Steendam R, Kops N, et al. Degradation, Intra-Articular Biocompatibility, Drug Release, and Bioactivity of Tacrolimus-Loaded Poly (D\u2013L-lactide-PEG)- b-poly(L-lactide) Multiblock Copolymer-Based Monospheres. ACS Biomater Sci Eng. 2018;4:2390\u2013403.","journal-title":"ACS Biomater Sci Eng"},{"key":"4196_CR77","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2019.07.030","volume":"309","author":"M Abou-ElNour","year":"2019","unstructured":"Abou-ElNour M, Ishak RAH, Tiboni M, Bonacucina G, Cespi M, Casettari L, et al. Triamcinolone acetonide-loaded PLA\/PEG-PDL microparticles for effective intra-articular delivery: synthesis, optimization, in vitro and in vivo evaluation. J Control Release. 2019;309:125\u201344.","journal-title":"J Control Release"},{"key":"4196_CR78","doi-asserted-by":"publisher","first-page":"e2004519","DOI":"10.1002\/smll.202004519","volume":"16","author":"J Yang","year":"2020","unstructured":"Yang J, Han Y, Lin J, Zhu Y, Wang F, Deng L, et al. Ball-bearing-inspired polyampholyte-modified microspheres as bio-lubricants attenuate osteoarthritis. Small. 2020;16:e2004519.","journal-title":"Small"},{"key":"4196_CR79","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1039\/C7NR07614B","volume":"10","author":"P Maudens","year":"2018","unstructured":"Maudens P, Meyer S, Seemayer CA, Jordan O, All\u00e9mann R. Self-assembled thermoresponsive nanostructures of hyaluronic acid conjugates for osteoarthritis therapy. Nanoscale. 2018;10:1845\u201354.","journal-title":"Nanoscale"},{"key":"4196_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ppsc.201600411","volume":"34","author":"G Palmieri","year":"2017","unstructured":"Palmieri G, Rinaldi A, Campagnolo L, Tortora M, Caso MF, Mattei M, et al. Hyaluronic acid nanoporous microparticles with long in vivo joint residence time and sustained release. Part Part Syst Charact. 2017;34:1\u20137.","journal-title":"Part Part Syst Charact"},{"key":"4196_CR81","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1021\/acsbiomaterials.0c00960","volume":"6","author":"LM Mancipe Castro","year":"2020","unstructured":"Mancipe Castro LM, Sequeira A, Garcia AJ, Guldberg RE. Articular cartilage- and synoviocyte-binding poly(ethylene glycol) nano-composite microgels as intra-articular drug delivery vehicles for the treatment of osteoarthritis. ACS Biomater Sci Eng. 2020;6:5084\u201395.","journal-title":"ACS Biomater Sci Eng"},{"key":"4196_CR82","doi-asserted-by":"publisher","unstructured":"Colville MJ, Huang LT, Schmidt S, Chen K, Vishwanath K, Su J, Williams RM, Bonassar LJ, Reesink HL, Paszek MJ. Recombinant manufacturing of multispecies biolubricants. BioRxiv. 2024;1\u201318.\u00a0https:\/\/doi.org\/10.1101\/2024.05.05.592580.","DOI":"10.1101\/2024.05.05.592580"},{"key":"4196_CR83","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2217\/nnm-2017-0335","volume":"13","author":"Q Hu","year":"2018","unstructured":"Hu Q, Chen Q, Yan X, Ding B, Chen D, Cheng L. Chondrocyte affinity peptide modified PAMAM conjugate as a nanoplatform for targeting and retention in cartilage. Nanomedicine (Lond). 2018;13:749\u201367.","journal-title":"Nanomedicine (Lond)"},{"key":"4196_CR84","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10895-013-1215-9","volume":"23","author":"SK Cool","year":"2013","unstructured":"Cool SK, Breyne K, Meyer E, De Smedt SC, Sanders NN. Comparison of in vivo optical systems for bioluminescence and fluorescence imaging. J Fluoresc. 2013;23:909\u201320.","journal-title":"J Fluoresc"},{"key":"4196_CR85","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/1947603511400184","volume":"2","author":"K Edsman","year":"2011","unstructured":"Edsman K, Hjelm R, L\u00e4rkner H, Nord LI, Karlsson A, Wiebensj\u00f6 \u00c5, et al. Intra-articular duration of Durolane\u2122 after single injection into the rabbit knee. Cartilage. 2011;2:384\u20138.","journal-title":"Cartilage"},{"key":"4196_CR86","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ijpharm.2013.08.016","volume":"456","author":"L Bedouet","year":"2013","unstructured":"Bedouet L, Pascale F, Moine L, Wassef M, Ghegediban SH, Nguyen N, et al. Intra-articular fate of degradable poly(ethyleneglycol)-hydrogel microspheres as carriers for sustained drug delivery. Int J Pharm. 2013;456:536\u201344.","journal-title":"Int J Pharm"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04196-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04196-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04196-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:02:54Z","timestamp":1791345774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04196-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":86,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4196"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04196-z","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}